XHE vs. IBRN
XHE (SPDR S&P Health Care Equipment ETF) and IBRN (iShares Neuroscience and Healthcare ETF) are both Health & Biotech Equities funds - XHE tracks the S&P Health Care Equipment Select Industry Index while IBRN tracks the NYSE FactSet Global Neuro Biopharma and MedTech Index. Both are passively managed. Over the past 3 years, XHE returned -6.57%/yr vs 11.10%/yr for IBRN. A 0.64 correlation means they provide meaningful diversification when combined. XHE charges 0.35%/yr vs 0.47%/yr for IBRN.
Performance
XHE vs. IBRN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XHE achieves a -11.59% return, which is significantly lower than IBRN's 4.62% return.
XHE
- 1D
- -0.95%
- 1M
- -4.49%
- YTD
- -11.59%
- 6M
- -10.52%
- 1Y
- -2.63%
- 3Y*
- -6.57%
- 5Y*
- -8.01%
- 10Y*
- 5.72%
IBRN
- 1D
- -4.52%
- 1M
- -1.90%
- YTD
- 4.62%
- 6M
- 12.73%
- 1Y
- 52.57%
- 3Y*
- 11.10%
- 5Y*
- —
- 10Y*
- —
XHE vs. IBRN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
XHE SPDR S&P Health Care Equipment ETF | -11.59% | -0.23% | 5.08% | -6.23% | -4.86% |
IBRN iShares Neuroscience and Healthcare ETF | 4.62% | 28.49% | -2.78% | 0.92% | 5.85% |
Correlation
The correlation between XHE and IBRN is 0.53, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.53 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.60 |
Correlation (All Time) Calculated using the full available price history since Aug 29, 2022 | 0.64 |
The correlation between XHE and IBRN shifts across timeframes, from 0.53 (1 year) to 0.64 (all time), reflecting how their relationship changes across market environments.
XHE vs. IBRN - Sectors Allocation Comparison
Sectors
XHE
IBRN
Healthcare
Industrials
-
Financial Services
-
Communication Services
-
Basic Materials
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
XHE
IBRN
Industrials
XHE
IBRN
-
Financial Services
XHE
IBRN
-
Communication Services
XHE
IBRN
-
Basic Materials
XHE
-
IBRN
-
Consumer Cyclical
XHE
-
IBRN
-
Consumer Defensive
XHE
-
IBRN
-
Energy
XHE
-
IBRN
-
Real Estate
XHE
-
IBRN
-
Technology
XHE
-
IBRN
-
Utilities
XHE
-
IBRN
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XHE vs. IBRN — Risk / Return Rank
XHE
IBRN
XHE vs. IBRN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Health Care Equipment ETF (XHE) and iShares Neuroscience and Healthcare ETF (IBRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XHE | IBRN | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.12 | 2.09 | -2.21 |
Sortino ratioReturn per unit of downside risk | -0.03 | 2.94 | -2.96 |
Omega ratioGain probability vs. loss probability | 1.00 | 1.34 | -0.34 |
Calmar ratioReturn relative to maximum drawdown | -0.21 | 6.30 | -6.51 |
Martin ratioReturn relative to average drawdown | -0.48 | 15.59 | -16.07 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XHE | IBRN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.12 | 2.09 | -2.21 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.33 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.25 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.40 | 0.37 | +0.03 |
Drawdowns
XHE vs. IBRN - Drawdown Comparison
The maximum XHE drawdown since its inception was -49.92%, which is greater than IBRN's maximum drawdown of -35.38%. Use the drawdown chart below to compare losses from any high point for XHE and IBRN.
Loading charts...
Drawdown Indicators
| XHE | IBRN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -49.92% | -35.38% | -14.54% |
Max Drawdown (1Y)Largest decline over 1 year | -18.29% | -8.80% | -9.49% |
Max Drawdown (3Y)Largest decline over 3 years | -32.62% | -35.38% | +2.76% |
Max Drawdown (5Y)Largest decline over 5 years | -49.92% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -49.92% | — | — |
Current DrawdownCurrent decline from peak | -41.39% | -6.28% | -35.11% |
Average DrawdownAverage peak-to-trough decline | -13.26% | -9.83% | -3.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.00% | 3.56% | +4.44% |
Volatility
XHE vs. IBRN - Volatility Comparison
The current volatility for SPDR S&P Health Care Equipment ETF (XHE) is 5.82%, while iShares Neuroscience and Healthcare ETF (IBRN) has a volatility of 7.66%. This indicates that XHE experiences smaller price fluctuations and is considered to be less risky than IBRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XHE | IBRN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.82% | 7.66% | -1.84% |
Volatility (6M)Calculated over the trailing 6-month period | 15.38% | 19.29% | -3.91% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.39% | 25.38% | -3.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.40% | 25.32% | -0.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.93% | 25.32% | -2.39% |
XHE vs. IBRN - Expense Ratio Comparison
XHE has a 0.35% expense ratio, which is lower than IBRN's 0.47% expense ratio.
Dividends
XHE vs. IBRN - Dividend Comparison
XHE's dividend yield for the trailing twelve months is around 0.09%, less than IBRN's 0.95% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBRN iShares Neuroscience and Healthcare ETF | 0.95% | 0.99% | 0.40% | 0.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XHE SPDR S&P Health Care Equipment ETF | 0.09% | 0.08% | 0.04% | 0.03% | 0.04% | 0.00% | 0.00% | 0.05% | 0.09% | 0.78% | 0.17% | 7.22% |
Frequently Asked Questions
XHE and IBRN have a correlation of 0.53, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IBRN has higher volatility (7.66%) compared to XHE (5.82%). In terms of maximum drawdown, XHE dropped -49.92% vs IBRN's -35.38%.
On 3-year performance, IBRN leads with 11.10% vs -6.57% for XHE. On fees, XHE is cheaper at 0.35% per year. On volatility, XHE has been the lower-risk option at 5.82%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, IBRN has performed better with a 11.10% return vs -6.57%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XHE is cheaper with a 0.35% expense ratio, compared with 0.47% for IBRN.
IBRN has the higher dividend yield at 0.95%, compared with 0.09% for XHE.
XHE tracks S&P Health Care Equipment Select Industry Index, while IBRN tracks NYSE FactSet Global Neuro Biopharma and MedTech Index. They also come from different issuers: State Street and iShares. Their fees differ too: 0.35% for XHE and 0.47% for IBRN.
IBRN currently has the higher Sharpe Ratio (2.09 vs -0.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XHE and IBRN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer